1. Home
  2. LNKS vs INDP Comparison

LNKS vs INDP Comparison

Compare LNKS & INDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNKS
  • INDP
  • Stock Information
  • Founded
  • LNKS 1995
  • INDP 2000
  • Country
  • LNKS Malaysia
  • INDP United States
  • Employees
  • LNKS N/A
  • INDP N/A
  • Industry
  • LNKS
  • INDP Biotechnology: Pharmaceutical Preparations
  • Sector
  • LNKS
  • INDP Health Care
  • Exchange
  • LNKS NYSE
  • INDP Nasdaq
  • Market Cap
  • LNKS 8.3M
  • INDP 7.4M
  • IPO Year
  • LNKS 2024
  • INDP N/A
  • Fundamental
  • Price
  • LNKS $0.62
  • INDP $0.42
  • Analyst Decision
  • LNKS
  • INDP Strong Buy
  • Analyst Count
  • LNKS 0
  • INDP 2
  • Target Price
  • LNKS N/A
  • INDP $8.50
  • AVG Volume (30 Days)
  • LNKS 38.7K
  • INDP 42.8K
  • Earning Date
  • LNKS 05-23-2025
  • INDP 05-14-2025
  • Dividend Yield
  • LNKS N/A
  • INDP N/A
  • EPS Growth
  • LNKS N/A
  • INDP N/A
  • EPS
  • LNKS N/A
  • INDP N/A
  • Revenue
  • LNKS $5,088,489.00
  • INDP N/A
  • Revenue This Year
  • LNKS N/A
  • INDP N/A
  • Revenue Next Year
  • LNKS N/A
  • INDP N/A
  • P/E Ratio
  • LNKS N/A
  • INDP N/A
  • Revenue Growth
  • LNKS N/A
  • INDP N/A
  • 52 Week Low
  • LNKS $0.45
  • INDP $0.43
  • 52 Week High
  • LNKS $10.27
  • INDP $3.10
  • Technical
  • Relative Strength Index (RSI)
  • LNKS N/A
  • INDP 36.36
  • Support Level
  • LNKS N/A
  • INDP $0.40
  • Resistance Level
  • LNKS N/A
  • INDP $0.48
  • Average True Range (ATR)
  • LNKS 0.00
  • INDP 0.05
  • MACD
  • LNKS 0.00
  • INDP 0.01
  • Stochastic Oscillator
  • LNKS 0.00
  • INDP 38.75

About LNKS LINKERS INDUSTRIES LIMITED

Linkers Industries Ltd is a company which acts as a manufacturer and a supplier of wire, cable harnesses with their manufacturing operations in Malaysia. Wire/cable harness refers to an assembly of wires/cables bound together with straps, cable ties and electrical tapes to transmit signals or electrical power. Company works closely with customers in each stage of a product's life cycle, including design, prototyping and production. Geographically company provides services in Thailand, Malaysia, Switzerland, United States of America, and many others, maximum revenue gained from Thailand.

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

Share on Social Networks: